Alyeska Investment Group’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.97M | Hold |
412,000
| – | – | 0.01% | 464 |
|
|
2025
Q1 | $3.4M | Buy |
+412,000
| New | +$3.4M | 0.01% | 385 |
|
|
2024
Q3 | – | Sell |
-11,369
| Closed | -$99.5K | – | 519 |
|
|
2024
Q2 | $99.5K | Buy |
+11,369
| New | +$99.5K | ﹤0.01% | 481 |
|
|
2024
Q1 | – | Sell |
-115,289
| Closed | -$1.91M | – | 434 |
|
|
2023
Q4 | $1.91M | Buy |
+115,289
| New | +$1.91M | 0.01% | 353 |
|
|
2021
Q2 | – | Sell |
-600
| Closed | -$341K | – | 701 |
|
|
2021
Q1 | $341K | Hold |
600
| – | – | ﹤0.01% | 679 |
|
|
2020
Q4 | $415K | Buy |
+600
| New | +$415K | 0.01% | 450 |
|